Bank of America’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-929,200
| Closed | -$215M | – | 7282 |
|
|
2025
Q3 | $215M | Buy |
929,200
+593,400
| +177% | +$121M | 0.01% | 776 |
|
|
2025
Q2 | $62.3M | Sell |
335,800
-459,100
| -58% | -$85.3M | ﹤0.01% | 1522 |
|
|
2025
Q1 | $167M | Buy |
794,900
+275,400
| +53% | +$53.5M | 0.01% | 803 |
|
|
2024
Q4 | $92.3M | Buy |
519,500
+107,400
| +26% | +$19.7M | 0.01% | 1080 |
|
|
2024
Q3 | $81.4M | Sell |
412,100
-4,500
| -1% | -$840K | 0.01% | 1204 |
|
|
2024
Q2 | $71.5M | Sell |
416,600
-38,300
| -8% | -$6.34M | 0.01% | 1219 |
|
|
2024
Q1 | $82.8M | Sell |
454,900
-274,400
| -38% | -$47.3M | 0.01% | 1135 |
|
|
2023
Q4 | $113M | Buy |
729,300
+149,000
| +26% | +$21.7M | 0.01% | 899 |
|
|
2023
Q3 | $86.5M | Buy |
580,300
+115,600
| +25% | +$17M | 0.01% | 966 |
|
|
2023
Q2 | $62.6M | Buy |
464,700
+192,300
| +71% | +$28.2M | 0.01% | 1155 |
|
|
2023
Q1 | $43.4M | Sell |
272,400
-169,000
| -38% | -$25.8M | ﹤0.01% | 1471 |
|
|
2022
Q4 | $71.3M | Buy |
441,400
+92,100
| +26% | +$14.1M | 0.01% | 1081 |
|
|
2022
Q3 | $46.9M | Buy |
349,300
+47,100
| +16% | +$6.76M | 0.01% | 1310 |
|
|
2022
Q2 | $46.3M | Sell |
302,200
-3,400
| -1% | -$520K | 0.01% | 1317 |
|
|
2022
Q1 | $49.5M | Sell |
305,600
-117,800
| -28% | -$17.1M | ﹤0.01% | 1369 |
|
|
2021
Q4 | $57.3M | Sell |
423,400
-25,000
| -6% | -$2.95M | 0.01% | 1326 |
|
|
2021
Q3 | $48.4M | Sell |
448,400
-165,600
| -27% | -$18.9M | 0.01% | 1378 |
|
|
2021
Q2 | $69.2M | Buy |
614,000
+430,600
| +235% | +$48.5M | 0.01% | 1162 |
|
|
2021
Q1 | $19.8M | Sell |
183,400
-46,000
| -20% | -$4.92M | ﹤0.01% | 2041 |
|
|
2020
Q4 | $24.6M | Buy |
229,400
+62,000
| +37% | +$5.96M | ﹤0.01% | 1697 |
|
|
2020
Q3 | $14.7M | Buy |
167,400
+33,700
| +25% | +$3.17M | ﹤0.01% | 1962 |
|
|
2020
Q2 | $13.1M | Sell |
133,700
-14,300
| -10% | -$1.26M | ﹤0.01% | 1977 |
|
|
2020
Q1 | $11.3M | Sell |
148,000
-482,200
| -77% | -$41.1M | ﹤0.01% | 1970 |
|
|
2019
Q4 | $55.8M | Buy |
630,200
+600
| +0.1% | +$49.8K | 0.01% | 1104 |
|
|
2019
Q3 | $47.7M | Sell |
629,600
-96,600
| -13% | -$6.62M | 0.01% | 1160 |
|
|
2019
Q2 | $52.8M | Buy |
726,200
+305,400
| +73% | +$24M | 0.01% | 1087 |
|
|
2019
Q1 | $33.9M | Sell |
420,800
-209,000
| -33% | -$17.1M | 0.01% | 1406 |
|
|
2018
Q4 | $58.1M | Buy |
629,800
+166,700
| +36% | +$14.7M | 0.01% | 914 |
|
|
2018
Q3 | $43.8M | Sell |
463,100
-115,000
| -20% | -$10.9M | 0.01% | 1190 |
|
|
2018
Q2 | $53.6M | Sell |
578,100
-154,700
| -21% | -$15.1M | 0.01% | 1042 |
|
|
2018
Q1 | $69.4M | Sell |
732,800
-525,300
| -42% | -$57.7M | 0.01% | 869 |
|
|
2017
Q4 | $122M | Buy |
1,258,100
+1,800
| +0.1% | +$170K | 0.02% | 646 |
|
|
2017
Q3 | $112M | Sell |
1,256,300
-56,000
| -4% | -$4.26M | 0.02% | 711 |
|
|
2017
Q2 | $95.2M | Buy |
1,312,300
+131,600
| +11% | +$8.85M | 0.02% | 716 |
|
|
2017
Q1 | $76.9M | Buy |
1,180,700
+242,100
| +26% | +$15.2M | 0.02% | 811 |
|
|
2016
Q4 | $58.8M | Buy |
938,600
+93,000
| +11% | +$5.68M | 0.01% | 912 |
|
|
2016
Q3 | $53.3M | Sell |
845,600
-51,300
| -6% | -$3.32M | 0.01% | 938 |
|
|
2016
Q2 | $55.5M | Buy |
896,900
+376,300
| +72% | +$22.9M | 0.01% | 919 |
|
|
2016
Q1 | $29.7M | Sell |
520,600
-561,800
| -52% | -$31.3M | 0.01% | 1265 |
|
|
2015
Q4 | $64.1M | Sell |
1,082,400
-68,100
| -6% | -$3.92M | 0.02% | 861 |
|
|
2015
Q3 | $62.6M | Sell |
1,150,500
-91,600
| -7% | -$5.96M | 0.02% | 852 |
|
|
2015
Q2 | $83.5M | Buy |
1,242,100
+472,700
| +61% | +$30.9M | 0.03% | 643 |
|
|
2015
Q1 | $45M | Sell |
769,400
-369,300
| -32% | -$22.3M | 0.02% | 874 |
|
|
2014
Q4 | $74.5M | Buy |
1,138,700
+265,500
| +30% | +$16.7M | 0.03% | 658 |
|
|
2014
Q3 | $50.4M | Buy |
873,200
+501,300
| +135% | +$27.8M | 0.02% | 844 |
|
|
2014
Q2 | $21M | Buy |
371,900
+203,400
| +121% | +$10.7M | 0.01% | 1369 |
|
|
2014
Q1 | $8.66M | Buy |
168,500
+78,200
| +87% | +$3.95M | ﹤0.01% | 1894 |
|
|
2013
Q4 | $4.77M | Sell |
90,300
-23,900
| -21% | -$1.17M | ﹤0.01% | 2521 |
|
|
2013
Q3 | $5.11M | Buy |
114,200
+101,200
| +778% | +$4.49M | ﹤0.01% | 2385 |
|
|
2013
Q2 | $537K | Buy |
+13,000
| New | +$569K | ﹤0.01% | 4679 |
|
Other funds holding ABBV
VCM
VPM
Bank of America's ABBV Position: Q1 2026 in Review
Bank of America reduced its AbbVie (ABBV) stake by 7.3% in Q1 2026, selling an estimated $419M and leaving 23,936,943 shares worth $5.21B. The position accounts for 0.38% of the portfolio, ranked #48.
Bank of America first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.9B in Q4 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Bank of America held 23,936,943 shares of AbbVie worth $5.21B as of Q1 2026.
- Bank of America sold 1,887,456 AbbVie shares in Q1 2026, an estimated $419M.
- AbbVie made up 0.38% of Bank of America's portfolio in Q1 2026, its #48 holding.
- Bank of America first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Bank of America's AbbVie position peaked at $5.9B in Q4 2025.
- 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.